Asahi Intecc Co., Japan’s leading maker of PTCA (percutaneous transluminal coronary angioplasty) guiding catheters, will start selling its neurovascular guidewires in the United States and Europe this month.
The Asahi Chikai and Asahi Chikai 10 micro guidewires were developed as workhorse devices to treat intracranial aneurysms and cerebral arteriovenous fistulas and malformations. Sold in Japan since January 2010, where they reportedly have a 40% market share, the guidewires balance distal flexibility with precise torqueability to ensure optimal performance in neurological interventional procedures, according to the company.
Approximately 110,000 cerebrovascular procedures are performed annually in Japan, the United States and Europe, according to Asahi Intecc.
The guidewires will be sold via a direct sales team in the United States and through local distributors in Europe.
Asahi Intecc won top honours at the MEDTEC Japan Innovation Awards in 2012 for successfully transforming its main business from manufacturing auto parts to making medical devices. The company has posted a video highlighting its history and current activities.
Asahi Intecc will exhibit at MD&M West in Anaheim, CA, USA, from 12 to 14 February 2013, and atMEDTEC Europe in Stuttgart, Germany, from 26 to 28 February 2013. The company has announced that it will demonstrate its neurovascular and peripheral models at MEDTEC Japan in Tokyo on 24 and 25 April 2013.